Overview
- Editors:
-
-
Ian M Gould
-
Department of Medical Microbiology, Aberdeen Royal Infirmary, Foresterhill, Australia
-
Jos WM Meer
-
Department of General Internal Medicine & Nijmegen University Centre for Infectious Diseases, Radboud University, Nijmegen Medical Centre, Nijmegen, The Netherlands
Complete reference to antibiotics, encompassing all aspects of policy, theory, and resistance
Editors are well-known and highly respected in the international infectious diseases community
Access this book
Other ways to access
Table of contents (16 chapters)
-
Front Matter
Pages I-XIII
-
-
- Jos W.M. van der Meer, Richard P.T.M. Grol
Pages 17-27
-
- Stephan Harbarth, Dominique L. Monnet
Pages 29-40
-
- Mical Paul, Roberto Cauda, Leonard Leibovici
Pages 41-67
-
-
-
- Fiona Cooke, Alison Holmes
Pages 93-112
-
- Duygu Yazgan Aksoy, Mine Durusu Tanriover, Serhat Unal
Pages 113-133
-
-
-
- Marc J.M. Bonten, Jan Jelrik Oosterheert
Pages 175-191
-
- Marìa V. Torres, Patricia Mu≁oz, Emilio Bouza
Pages 193-207
-
-
-
-
- Jan A.J.W. Kluytmans, Bram M.W. Diederen
Pages 253-269
-
Back Matter
Pages 271-285
About this book
In 1971, I started a fellowship in infectious diseases and medical microbiology at the Channing Laboratory of the Harvard Medical Service at Boston City Hospital. My mentor, Dr. Maxwell Finland, had encouraged me to return there from the Center for Disease Control (as CDC was known then), where I had studied inf- tious diseases epidemiology and hospital-associated infection epidemiology, with the idea that we would review the demographic patterns of bacteremia and several other infections during Dr. Finland’s long tenure at the hospital. We did so, but I was surprised to find that he also invited me to help with the assessment of the success or failure of the programs to control antimicrobial use that he and c- leagues had put into place at the hospital over several years. The paper describing that review finally was published in 1974, after a long and tortuous process of review at several journals. Several reviewers felt that such attempts to improve use amounted to interference with the patient’s physician to do what was best. Others felt that such programs focused incorrectly on a subject other than treating the current patient. Fortunately, today, it is clear that antimicrobial resistance results in major part, but not entirely, from the ways that we use antimicrobial agents, and that the ov- all interests of patients in general, as well as those of society, are well served by efforts to use these drugs as well as possible.
Editors and Affiliations
-
Department of Medical Microbiology, Aberdeen Royal Infirmary, Foresterhill, Australia
Ian M Gould
-
Department of General Internal Medicine & Nijmegen University Centre for Infectious Diseases, Radboud University, Nijmegen Medical Centre, Nijmegen, The Netherlands
Jos WM Meer
